Eureka Acquisition Corp 8-K

What Happened

• Eureka Acquisition Corp (EURK) filed an 8-K reporting that at an Extraordinary General Meeting on June 29, 2026 shareholders approved a charter amendment to extend the company’s deadline to complete a business combination to July 3, 2026, with the ability to take up to 12 one‑month extensions (Monthly Extensions) for a final deadline of July 3, 2027. The charter amendment (Fourth Amended and Restated Memorandum and Articles of Association) is filed as an exhibit.
• On June 30, 2026 the company entered into an amendment to its investment management trust agreement with Continental Stock Transfer & Trust Company. The Trust Amendment requires a Monthly Extension Fee of $8,253.03 to be deposited into the company’s trust account for each monthly extension. If a Monthly Extension Fee is not deposited by the 3rd day of the month (beginning July 3, 2026), the company has a 30‑day cure period to pay past due amounts; failure to cure requires the company to cease operations and liquidate as if it failed to complete a business combination.

Key Details

• Extraordinary General Meeting date: June 29, 2026; Trust Amendment date: June 30, 2026.
• Monthly Extension Fee: $8,253.03 per Monthly Extension; Cure Period: 30 days to cure missed payments.
• Charter vote result (for the extension): 3,135,502 for; 611,629 against; 0 abstain. Shareholder turnout ~77.7% of votes.
• Redemption impact: 2,655,132 Class A shares were redeemed in connection with the vote; outstanding after redemptions: 733,101 Class A shares and 1,437,500 Class B shares.
• Auditor appointment approved: Marcum Asia CPAs LLP was engaged as independent registered public accounting firm for fiscal year ending Sept 30, 2026 (vote: 3,195,270 for; 551,861 against).

Why It Matters

• The company now has a formal, extended timeline to complete a business combination through July 3, 2027, but each one‑month extension requires about $8.25k to be deposited into the trust — a recurring drain on trust funds that investors should track.
• The trust amendment includes a strict enforcement mechanism: failing to fund the fee (and not curing within 30 days) forces immediate wind‑down and liquidation as if the SPAC failed to complete a deal. That creates a clear cash‑funding milestone investors should monitor.
• Large redemptions reduced the public Class A float (down to 733,101 shares), which can affect voting dynamics, remaining trust account balance per share, and the company’s ability to consummate a transaction.